Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction of remission in rheumatoid arthritis patients with low disease activity by additional infliximab therapy
2005-004530-40Phase 3Terminated
- Sponsor
- AESCA Pharma
- Start
- Nov 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of infliximab in rheumatoid arthritis (RA), sponsored by AESCA Pharma. Started Nov 2005; status: terminated.
02
Drugs
infliximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2005-004530-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004530-40.